Literature DB >> 22901888

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys.

Gary A Giovino1, Sara A Mirza, Jonathan M Samet, Prakash C Gupta, Martin J Jarvis, Neeraj Bhala, Richard Peto, Witold Zatonski, Jason Hsia, Jeremy Morton, Krishna M Palipudi, Samira Asma.   

Abstract

BACKGROUND: Despite the high global burden of diseases caused by tobacco, valid and comparable prevalence data for patterns of adult tobacco use and factors influencing use are absent for many low-income and middle-income countries. We assess these patterns through analysis of data from the Global Adult Tobacco Survey (GATS).
METHODS: Between Oct 1, 2008, and March 15, 2010, GATS used nationally representative household surveys with comparable methods to obtain relevant information from individuals aged 15 years or older in 14 low-income and middle-income countries (Bangladesh, Brazil, China, Egypt, India, Mexico, Philippines, Poland, Russia, Thailand, Turkey, Ukraine, Uruguay, and Vietnam). We compared weighted point estimates and 95% CIs of tobacco use between these 14 countries and with data from the 2008 UK General Lifestyle Survey and the 2006-07 US Tobacco Use Supplement to the Current Population Survey. All these surveys had cross-sectional study designs.
FINDINGS: In countries participating in GATS, 48·6% (95% CI 47·6-49·6) of men and 11·3% (10·7-12·0) of women were tobacco users. 40·7% of men (ranging from 21·6% in Brazil to 60·2% in Russia) and 5·0% of women (0·5% in Egypt to 24·4% in Poland) in GATS countries smoked a tobacco product. Manufactured cigarettes were favoured by most smokers (82%) overall, but smokeless tobacco and bidis were commonly used in India and Bangladesh. For individuals who had ever smoked daily, women aged 55-64 years at the time of the survey began smoking at an older age than did equivalently aged men in most GATS countries. However, those individuals who had ever smoked daily and were aged 25-34-years when surveyed started to do so at much the same age in both sexes. Quit ratios were very low (<20% overall) in China, India, Russia, Egypt, and Bangladesh.
INTERPRETATION: The first wave of GATS showed high rates of smoking in men, early initiation of smoking in women, and low quit ratios, reinforcing the view that efforts to prevent initiation and promote cessation of tobacco use are needed to reduce associated morbidity and mortality. FUNDING: Bloomberg Philanthropies' Initiative to Reduce Tobacco Use, Bill and Melinda Gates Foundation, Brazilian and Indian Governments.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22901888     DOI: 10.1016/S0140-6736(12)61085-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  276 in total

1.  High cardiovascular mortality in Russia: role of alcohol versus smoking, blood pressure, and treatment.

Authors:  David A Leon; Majid Ezzati
Journal:  Nat Rev Cardiol       Date:  2015-10-27       Impact factor: 32.419

Review 2.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

3.  Tobacco Smoking: Facts and actions.

Authors:  Moeness M Alshishtawy
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

4.  Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study.

Authors:  Arash Etemadi; Hossein Poustchi; Cindy M Chang; Benjamin C Blount; Antonia M Calafat; Lanqing Wang; Victor R De Jesus; Akram Pourshams; Ramin Shakeri; Meredith S Shiels; Maki Inoue-Choi; Bridget K Ambrose; Carol H Christensen; Baoguang Wang; Gwen Murphy; Xiaoyun Ye; Deepak Bhandari; Jun Feng; Baoyun Xia; Connie S Sosnoff; Farin Kamangar; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-08       Impact factor: 4.254

5.  The Effect of Working in a Smoke-Free Workplace on use of Smoking and Smokeless Tobacco.

Authors:  Hasan Kahraman; Mustafa Haki Sucaklı; Nurhan Atilla; Hüseyin Arpağ; Fulsen Bozkuş; Nurhan Köksal
Journal:  Turk Thorac J       Date:  2017-01-01

6.  Smoking Trajectories during the Perinatal Period and Their Risk Factors: The Nationally Representative French ELFE (Etude Longitudinale Française Depuis l'Enfance) Birth Cohort Study.

Authors:  Fabienne El-Khoury; Anne-Laure Sutter-Dallay; Judith Van Der Waerden; Pamela Surkan; Silvia Martins; Katherine Keyes; Blandine de Lauzon-Guillain; Marie-Aline Charles; Maria Melchior
Journal:  Eur Addict Res       Date:  2017-09-02       Impact factor: 3.015

Review 7.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 8.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

9.  Cigarette smoking among patients with chronic diseases.

Authors:  Tatiane da S Campos; Kimber P Richter; A Paula Cupertino; Arise G S Galil; Eliane F C Banhato; Fernando A B Colugnati; Marcus G Bastos
Journal:  Int J Cardiol       Date:  2014-04-22       Impact factor: 4.164

10.  The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.

Authors:  Yun Hu; Daniel Smith; Evan Frazier; Reece Hoerle; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2016-08-18       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.